CDK2 and non-small cell lung carcinoma: TBC1D23 was shown to promote NSCLC proliferation by upregulating cyclin B1, cyclin D1, CDK2 and CDK6 and promote NSCLC migration and invasion by upregulating RhoA, RhoC and MMP2.